Ironwood Pharma Financial Overview
Ironwood Pharma's market cap is currently $575.88M. The company's EPS TTM is $0.23; its P/E ratio is 22.93; Ironwood Pharma is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
